181 related articles for article (PubMed ID: 16000280)
41. Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.
Seibyl JP; Zea-Ponce Y; Brenner L; Baldwin RM; Krystal JH; Offord SJ; Mochoviak S; Charney DS; Hoffer PB; Innis RB
J Nucl Med; 1996 Jan; 37(1):11-5. PubMed ID: 8543979
[TBL] [Abstract][Full Text] [Related]
42. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
Goodman MM; Chen P; Plisson C; Martarello L; Galt J; Votaw JR; Kilts CD; Malveaux G; Camp VM; Shi B; Ely TD; Howell L; McConathy J; Nemeroff CB
J Med Chem; 2003 Mar; 46(6):925-35. PubMed ID: 12620070
[TBL] [Abstract][Full Text] [Related]
44. Validation of parametric methods for [¹¹C]PE2I positron emission tomography.
Jonasson M; Appel L; Engman J; Frick A; Nyholm D; Askmark H; Danfors T; Sörensen J; Furmark T; Lubberink M
Neuroimage; 2013 Jul; 74():172-8. PubMed ID: 23435214
[TBL] [Abstract][Full Text] [Related]
45. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.
Catafau AM; Danus M; Bullich S; Llop J; Perich J; Cunningham VJ; Plaza P; Penengo MM; Eersels JL; Squassante L; Ros D; Barbanoj M
J Nucl Med; 2006 Jun; 47(6):919-28. PubMed ID: 16741300
[TBL] [Abstract][Full Text] [Related]
46. SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.
Fischman AJ; Babich JW; Elmaleh DR; Barrow SA; Meltzer P; Hanson RN; Madras BK
J Nucl Med; 1997 Jan; 38(1):144-50. PubMed ID: 8998169
[TBL] [Abstract][Full Text] [Related]
47. A bolus/infusion paradigm for the novel NMDA receptor SPET tracer [123I]CNS 1261.
Bressan RA; Erlandsson K; Mulligan RS; Gunn RN; Cunningham VJ; Owens J; Cullum ID; Ell PJ; Pilowsky LS
Nucl Med Biol; 2004 Feb; 31(2):155-64. PubMed ID: 15013480
[TBL] [Abstract][Full Text] [Related]
48. Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodies.
Ziebell M; Andersen BB; Pinborg LH; Knudsen GM; Stokholm J; Thomsen G; Karlsborg M; Høgh P; Mørk ML; Hasselbalch SG
J Nucl Med; 2013 Jul; 54(7):1072-6. PubMed ID: 23637201
[TBL] [Abstract][Full Text] [Related]
49. Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive-compulsive disorder.
Kim CH; Koo MS; Cheon KA; Ryu YH; Lee JD; Lee HS
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1637-43. PubMed ID: 14513291
[TBL] [Abstract][Full Text] [Related]
50. Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects.
Kim HJ; Im JH; Yang SO; Moon DH; Ryu JS; Bong JK; Nam KP; Cheon JH; Lee MC; Lee HK
J Nucl Med; 1997 Nov; 38(11):1703-11. PubMed ID: 9374337
[TBL] [Abstract][Full Text] [Related]
51. Absolute quantification in dopaminergic neurotransmission SPECT using a Monte Carlo-based scatter correction and fully 3-dimensional reconstruction.
Cot A; Falcón C; Crespo C; Sempau J; Pareto D; Bullich S; Lomeña F; Calviño F; Pavía J; Ros D
J Nucl Med; 2005 Sep; 46(9):1497-504. PubMed ID: 16157533
[TBL] [Abstract][Full Text] [Related]
52. PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter.
Emond P; Guilloteau D; Chalon S
CNS Neurosci Ther; 2008; 14(1):47-64. PubMed ID: 18482099
[TBL] [Abstract][Full Text] [Related]
53. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
[TBL] [Abstract][Full Text] [Related]
54. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.
Kim SE; Choi JY; Choe YS; Choi Y; Lee WY
J Nucl Med; 2003 Jun; 44(6):870-6. PubMed ID: 12791812
[TBL] [Abstract][Full Text] [Related]
55. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
Harada N; Ohba H; Fukumoto D; Kakiuchi T; Tsukada H
Synapse; 2004 Oct; 54(1):37-45. PubMed ID: 15300883
[TBL] [Abstract][Full Text] [Related]
56. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
[TBL] [Abstract][Full Text] [Related]
57. Quantification of nicotinic acetylcholine receptors in human brain using [123I]5-I-A-85380 SPET.
Fujita M; Ichise M; van Dyck CH; Zoghbi SS; Tamagnan G; Mukhin AG; Bozkurt A; Seneca N; Tipre D; DeNucci CC; Iida H; Vaupel DB; Horti AG; Koren AO; Kimes AS; London ED; Seibyl JP; Baldwin RM; Innis RB
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1620-9. PubMed ID: 14523584
[TBL] [Abstract][Full Text] [Related]
58. Quantitative Analysis of Dynamic 123I-mIBG SPECT Imaging Data in Healthy Humans with a Population-Based Metabolite Correction Method.
Wu J; Lin SF; Gallezot JD; Chan C; Prasad R; Thorn SL; Stacy MR; Huang Y; Zonouz TH; Liu YH; Lampert RJ; Carson RE; Sinusas AJ; Liu C
J Nucl Med; 2016 Aug; 57(8):1226-32. PubMed ID: 27081169
[TBL] [Abstract][Full Text] [Related]
59. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.
Zhu Z; Guo N; Narendran R; Erritzoe D; Ekelund J; Hwang DR; Bae SA; Laruelle M; Huang Y
Nucl Med Biol; 2004 Nov; 31(8):983-94. PubMed ID: 15607480
[TBL] [Abstract][Full Text] [Related]
60. Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT.
Fujita M; Tamagnan G; Zoghbi SS; Al-Tikriti MS; Baldwin RM; Seibyl JP; Innis RB
J Nucl Med; 2000 Sep; 41(9):1552-60. PubMed ID: 10994738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
